55 results on '"Dubroff, Jacob"'
Search Results
2. Total-body imaging of mu-opioid receptors with [11C]carfentanil in non-human primates
3. State of Art of Molecular Imaging in the Diagnosis and Treatment of Dementia
4. Pharmacokinetic effects of a single-dose nutritional ketone ester supplement on brain ketone and glucose metabolism in alcohol use disorder
5. Reply: Molecular Imaging of Pulmonary Inflammation: Claiming That Vaping Is More Harmful Than Smoking Is Unsupported
6. Molecular imaging of pulmonary inflammation in electronic and combustible cigarette users: a pilot study
7. Tau accumulation and degeneration differ across functional networks in atypical Alzheimer's disease phenotypes
8. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis
9. Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies
10. Perfusion-only imaging in pregnant women: A comparative reader study with implications for practice patterns
11. [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease
12. Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline
13. Using 18F-NOS PET Imaging to Measure Pulmonary Inflammation in Electronic and Combustible Cigarette Users: A Pilot Study
14. Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function
15. Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism
16. Stable Extent of Recurrently Active Cardiac and Cutaneous Sarcoidosis
17. Reduced longitudinal change in 18 F‐flortaucipir PET is associated with clinical phenotype in atypical Alzheimer’s disease
18. Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging
19. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination
20. Clinical Predictors of Underlying Neurodegeneration in Drug-Induced Parkinsonism (4982)
21. Quantitative [18]FDG PET asymmetry features predict long-term seizure recurrence in refractory epilepsy
22. 99mTc-Mebrofenin SPECT/CT in Hepatic Infarction
23. Frontiers in Neuroscience Imaging
24. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
25. The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes
26. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy
27. PennPET Explorer: Human Imaging on a Whole-Body Imager
28. UTILIZING RUBIDIUM-82 CARDIAC POSITRON EMISSION TOMOGRAPHY REGIONAL MYOCARDIAL BLOOD FLOW TO DEVELOP NAIVE BAYES CLASSIFIER FOR CORONARY ARTERY DISEASE PREDICTION
29. Selectivity of probes for PET imaging of dopamine D3 receptors
30. Sensory Dysfunction in Early Parkinson's Disease
31. Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride
32. Recognizing common PET patterns in neurodegenerative dementia
33. Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
34. Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia
35. Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism
36. Emerging PET/MRI applications in neuroradiology and neuroscience
37. Uterine Cervical Metastasis From Primary Rectal Adenocarcinoma on PET/CT and MRI
38. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism
39. Will PET Amyloid Imaging Lead to Overdiagnosis of Alzheimer Dementia?
40. Can drug-induced Parkinsonism reveal pre-motor Parkinson disease? (P6.054)
41. MYOCARDIAL BLOOD FLOW RESERVE: A BIOMARKER FOR ADVERSE CARDIOVASCULAR OUTCOMES?
42. Point pressure sensitivity in early stage Parkinson's disease
43. Taste function in early stage treated and untreated Parkinson’s disease
44. Natalizumab-Induced Progressive Multifocal Leukoencephalopathy
45. Suprathreshold odor intensity perception in early-stage Parkinson's disease
46. An Overview of PET Neuroimaging
47. An open-label efficacy trial of escitalopram for night eating syndrome
48. Frequency and Clinicopathological Characteristics of Presenilin 1 Gly206Ala Mutation in Puerto Rican Hispanics with Dementia
49. A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation
50. μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.